Democrats Call For Price Gouging Regulator, Medicare Negotiation, Transparency Reporting, But Silent On Generics, Value-Based Payments

Congressional Democrats laid out Monday (July 24) a slate of proposals for lowering drug prices, including setting up an independent regulator to monitor “price gouging” of prescription drugs, allowing Medicare Part D to negotiate drug prices and requiring drug manufacturers to provide HHS with justification for any significant price hikes. An industry-backed coalition slammed the platform for not proposing ways to increase generic competition or advance value-based arrangements. The coalescing of top Democrats around drug pricing solutions comes after one...